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Abstract
Background: Pyk2 is a non-receptor cytoplasmic tyrosine kinase that belongs to the focal adhesion kinase family and 
has been implicated in neutrophil spreading and respiratory burst activity caused by TNF-α. However, the role of Pyk2 
in neutrophil migration is incompletely defined. In this study, we tested the hypothesis that Pyk2 regulates the 
migration of neutrophil-like differentiated HL-60 cells subsequent to β2-integrin mediated cell adhesion.
Methods: HL-60 cells were induced to differentiate into neutrophil-like cells (dHL60) by incubation in medium 
containing 1.25% DMSO for up to 4 days. Pyk2 expression and tyrosine phosphorylation was measured by Western blot 
analysis. Adhesion of dHL60 cells to plated fibrinogen was measured by residual myeloperoxidase activity. dHL60 cell 
migration was evaluated using a 96-well chemoTx chamber.
Results: Western blot analysis demonstrated that hematopoietic Pyk2 was predominantly expressed after HL60 cell 
differentiation. Pyk2 was tyrosine phosphorylated upon adhesion of dHL60 cells to plated fibrinogen in the presence of 
fMLP. By contrast, tyrosine phosphorylation of Pyk2 was insignificant in dHL60 cells treated in suspension with fMLP. 
Antibodies against CD18 blocked both phosphorylation of Pyk2 and adhesion of dHL60 cells to fibrinogen, 
demonstrating that phosphorylation of Pyk2 was β2-integrin dependent. TAT-Pyk2-CT, a dominant negative fusion 
protein in which the TAT protein transduction domain was fused to the c-terminal Pyk2, attenuated fMLP-stimulated 
spreading, migration and phosphorylation of endogenous Pyk2 without blocking adhesion of dHL-60 cells to 
fibrinogen. Similarly, silencing of Pyk2 expression by siRNA in dHL60 cells also attenuated dHL60 cell migration caused 
by fMLP. Phospho-Pyk2 was evenly distributed around cell membrane circumferentially in unstimulated dHL-60 cells 
adherent to plated fibrinogen. In dHL60 cells treated with fMLP to cause cell spreading and polarization, Pyk2 was 
concentrated at the leading edge of pseudopods or at the trailing edge of uropods during migration of neutrophilic 
dHL-60 cells.
Conclusions: We conclude that Pyk2 is activated by β2-integrin adhesion. The activated concentration of Pyk2 and 
colocalization with F-actin in pseudopodia suggests that Pyk2 may regulate cell spreading and migration in dHL60 
cells.
Background
Polymorphonuclear neutrophils (PMNs) play a central
role in the acute inflammatory response and are also
closely associated with tissue injury [1]. Full activation of
neutrophils by a soluble inflammatory stimulus requires a
co-stimulatory signal initiated by integrin binding to
endothelial cells or extracellular matrix proteins [2,3].
Integrins fix cellular protrusions to extracellular matrix
proteins, interact with the intracellular actin cytoskele-
ton, and trigger the association of many different signal-
ing proteins at focal contacts [4].
Proline-rich tyrosine kinase 2 (Pyk2), also known as cell
adhesion kinase β, is a non-receptor cytoplasmic tyrosine
kinase that belongs to the focal adhesion kinase family
[5]. Focal adhesion kinases are responsible for transfer-
ring signals from integrins to downstream signaling cas-
cades that regulate cell growth and migration in adherent
cells [6,7]. Pyk2 is expressed abundantly in hematopoietic
cells and neural cells [8,9]. Human neutrophils express
both FAK and Pyk2, but only Pyk2 appears to regulate
neutrophil function [10,11]. Previous studies have identi-
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Page 2 of 9fied Pyk2 in human neutrophils, localized it to focal
adhesion-like structures, and demonstrated its associa-
tion with paxillin during stimulation of adherent neutro-
phils by TNFα [12]. However, the role of Pyk2 in
neutrophil migration is incompletely defined.
Differentiated HL60 cells are commonly used as a
model system for neutrophil migration [13]. Human
blood neutrophils have a short half-life in vitro and are
terminally differentiated. Genetic modification of Pyk2
expression in mature cells such as neutrophils using cur-
rent techniques has been largely unsuccessful. Therefore
in this study, we chose the differentiated HL60 cells as a
model for human neutrophils to study the role of Pyk2 in
neutrophil migration. In these studies, we found that the
hematopoietic isoform of Pyk2 is predominantly
expressed in dimethyl sulfoxide (DMSO)-differentiated
HL-60 (dHL60) cells. Stimulation of dHL60 cells with
chemotactic peptide formyl-Met-Leu-Phe (fMLP)
induced tyrosine phosphorylation of Pyk2 subsequent to
β2 integrin adhesion. Using transduction of TAT-conju-
gated Pyk2-derived C-terminal protein (amino acid 680-
1009) as a specific inhibitor, we demonstrated that Pyk2
inhibition blocked significantly fMLP-induced migration
without blocking the ability of dHL60 cells to adhere to
plated fibrinogen. Phospho-Pyk2 was co-localized with F-
actin, mainly at the leading edge of lamellipodia in
migrating dHL-60 cells adherent to plated fibrinogen.
Our data indicate that Pyk2 is activated upon β2-integrin
binding to fibrinogen and likely facilitates cell spreading
and migration by co-localizing with cytoskeletal struc-
tures in response to chemoattractants.
Methods
Materials
HL-60 cells and RPMI 1640 medium were obtained from
American Type Culture Collection (Manassas, VA). Fetal
bovine serum (FBS) was purchased from Hyclone (Logan,
UT). L-glutamine was obtained from Invitrogen (Eugene,
OR). Fibrinogen (Fg), dimethyl sulfoxide (DMSO) and
formyl-Met-Leu-Phe (fMLP) were obtained from Sigma-
Aldrich (St. Louis, MO). The primary antibodies utilized
in this study include anti-Pyk2, anti-tyrosine 402 phos-
pho-Pyk2 (Cell Signaling, MA), mouse IgG (Southern
biotech, UT), and anti-CD18 mAb (7E4, Ancell, MN).
The secondary antibodies include horseradish peroxide
conjugated anti-mouse and anti-rabbit antibodies from
Amersham (Arlington Heights, IL), BODIPY FL goat
anti-rabbit IgG, Alexa Fluor 594 goat anti-mouse IgG
(H+L) and Alexa Fluor 647 phalloidin from Invitrogen
Molecular Probes (Eugene, OR). 96-well microplates for
adhesion assay were purchased from Costar (Corning,
NY). Migration assay microplates were purchased from
Neuro Probe (Gaitherberg, MD). TAT-Pyk2-CT was pro-
duced in our laboratory as described previously [14,15].
HL-60 Cell culture and differentiation
HL-60 cells were cultured in RPMI-1640 medium supple-
mented with 10% fetal bovine serum, 400 mM L-glu-
tamine, 50 μM gentamycin, 25 mM HEPES, 2 g/L sodium
bicarbonate, 1 mM sodium pyruvate in a humid atmo-
sphere of 5% CO2 at 37°C. For differentiation into a neu-
trophilic phenotype, HL-60 cells were resuspended in
fresh medium at a concentration of 105/ml and then dif-
ferentiated with 1.25% (v/v) DMSO for up to 9 days [16].
Cell viability was assessed by exclusion of 0.2% trypan
blue and was routinely >90% before and after differentia-
tion. Assessment of neutrophilic differentiation was per-
formed on days 0, 3, 6, 9 by several criteria including 1)
morphological change as nuclear segmentation and gran-
ules using May-Grunwald Giemsa staining, 2) CD11b
expression detected by flow cytometry and 3) responsive-
ness to PAF, fMLP or TNF-α stimulated adhesion to
fibrinogen-coated plates. dHL60 cells that were differen-
tiated for 4-6 days were used for adhesion and migration
assays.
Adhesion assay
dHL60 cell adhesion was assessed as the residual
myeloperoxidase (MPO) activity of adherent cells [17,18].
96-well microplates were coated with 100 μg/ml Fg over-
night at 4°C [19]. dHL60 cells (105) in HBSS containing
0.2% BSA were seeded on to each well of a microplate
with or without 10-6 M fMLP in a total volume of 100 μl
for 30 min at 37°C. After incubation, the reaction wells
were washed with HBSS 3 times. Serial dilutions of the
original cell suspension were added to the empty wells to
generate the standard curve. 100 μl of the myeloperoxi-
dase substrate (0.01% H2O2, 0.167 mg/mL O-dianisidine
dihydrochloride and 0.5% hexadecyltrimethylammo-
nium bromide in 50 mM potassium phosphate buffer, pH
5.5) was added to each well, and the reaction was termi-
nated with 4N sulphuric acid. Absorbance was then mea-
sured at 405 nm in a microplate reader (Molecular
devices, Sunnyvale, CA). The adherent cells were
expressed as percentage of the total cells added.
The blocking effect of mouse monoclonal antibodies
(mAb) against the common β chain of β2 integrin, anti-
CD18 (clone 7E4), was tested by preincubation of 10 μg/
ml antibodies with dHL60 cells for 30 min at 4°C before
adding to the 96-well microplates. Similarly, the inhibi-
tory effect of TAT-Pyk2-CT on adhesion of dHL60 cells
to plated Fg was assessed after 30 min preincubation at
37°C.
Migration assay
dHL60 cell migration was evaluated using a 96-well
chemoTx chamber as described previously [15,20].
dHL60 cells were pretreated with TAT-Pyk2-CT or TAT-
GFP control as above. dHL60 cells then were added to the
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with 5 μm pore filters and allowed to migrate for 90 min
at 37°C in 5% CO2 towards the lower chamber containing
10-8 M fMLP. Migrated cells from lower chamber were
centrifuged at 400 g for 10 min and collected at the bot-
tom of the lower chambers. As described for the adhesion
assay, MPO activity in the migrated cells was quantitated
against a standard curve of diluted cells, and the result
was expressed as a percentage of cells added to the top of
the plate.
Spreading assay
dHL60 cells were pre-treated with TAT-Pyk2-CT and
TAT-GFP as above. Cells were then added to fibrinogen
(Fg)-coated 8-well chamber slides containing 10-6 M
fMLP and incubated for 30 min at 37°C in 5% CO2. Cells
were viewed through a phase-contrast microscope, and
selected fields typical of each slide were photographed for
analysis.
Western blot analysis
dHL60 cell lysates were prepared by boiling with SDS
sample buffer for 5 min. Whole cell lysates were sepa-
rated by 10% SDS-PAGE and transferred to polyvi-
nylidene fluoride membranes. The membranes were
blocked with 2% bovine serum albumin (BSA) in Tris-
buffered saline plus 0.1% Tween 20 (TBS/T) for 60 min at
37°C. This was followed by incubation with primary anti-
bodies (1:1000) in TBS/T overnight at 4°C. The mem-
brane was then washed and incubated with horseradish
peroxidase conjugated anti-rabbit or mouse secondary
antibodies (1:3000) in TBS/T for 60 min. After washing
with TBS/T 3 times, enhanced chemiluminescence (ECL)
assays were performed to visualize bands on X-ray films.
Confocal microscopy
dHL60 cells (2 × 105) were preincubated with TAT-Pyk2-
CT or TAT-GFP control as above. Cells were plated onto
8-chamber glass slides coated with 100 μg/ml Fg and
incubated with 10-6 M fMLP at 37°C for 30 min. After fix-
ation with 1% paraformaldehyde for 10 min, cells were
permeabilized with 0.1% Triton-X100 in PBS for 4 min.
The permeabilized cells then were incubated with Alexa
Fluor 647-phalloidin for 60 min. To visualize the localiza-
tion of phospho-Pyk2, cells were incubated with anti-
phospho-Pyk2 antibody (1:40) diluted in PBS for 60 min
and then incubated with Bodipy FL conjugated goat anti-
rabbit IgG (1:1000) for another 60 min. After washing
with PBS 3 times, cells were then analyzed with a laser-
scanning confocal microscope imaging system (Leica SP2
AOBS, Mannheim, Germany). Photomicrographs were
focused at the plane of cell contact with the substratum.
Silencing of Pyk2 expression in dHL60 cells
A mixture of three separate siRNA duplexes targeting
human Pyk2 were purchased from Dharmacon (Catalog
#M-003165-03, Lafayette, CO). A single non-targeting
scramble siRNA duplex (Catalog #D-001210-01) was
used as control siRNA. HL60 cells were differentiated
with 1.25% DMSO for 3 days, and 2 μM siRNA was then
transfected into 4 × 106 cells in 100 μl of Nucleofector
Solution V (Amaxa) using the T-019 program on the
Nucleofector II machine (Amaxa), according to the man-
ufacturer's recommendation (Lonza Walkerrsville Inc.
Walkersville, MD). The cells then were recovered in
medium with 1.25% DMSO and harvested 72 h later. The
expression of Pyk2 after transfection was evaluated by
Western blotting.
Statistics
The results are expressed as Mean ± standard error of the
mean. Data were analyzed using one-way ANOVA fol-
lowed by Fisher's least significant difference method of
post hoc analysis or paired t test; p < 0.05 was considered
to be statistically significant.
Results
Neutrophilic differentiation and expression of Pyk2 in HL-
60 cells
In preliminary studies, differentiation of HL60 cells to
neutrophil-like cells was confirmed by 1) morphologic
change including nuclear segmentation, 2) CD11b
expression and 3) the ability to respond to PAF, TNFα or
fMLP in adhesion and migration assays. For subsequent
experiments requiring cell replication and characteriza-
tion, dHL-60 cells thus were used to model human neu-
trophils.
The predominant Pyk2 isoform differed slightly
between human neutrophils and dHL60 cells. Pyk2 was
not expressed in undifferentiated HL-60 cells. After dif-
ferentiation for ≥ 3 days, two isoforms of Pyk2 were
detected in dHL60 cells (Fig. 1A). The lower molecular
weight (~105 kDa) Pyk2H was the predominant isoform
expressed in dHL-60 cells. The full-length Pyk2 isoform
(~110 kDa) was weakly expressed or absent in these cells.
In contrast to dHL60 cells, mature human blood neutro-
phils expressed only the full-length Pyk2 isoform (Fig.
1B). There is no known functional difference between the
two isoforms (see discussion).
Tyrosine phosphorylation of Pyk2 is dependent on 
integrin-mediated cell adhesion
Adhesion to plated Fg greatly augmented Pyk2 phospho-
rylation. Phosphorylation of Pyk2 was only weakly
detected in dHL-60 cells suspended in buffer after activa-
tion 10-6 M fMLP. By contrast, Pyk2 phosphorylation was
substantially induced in fMLP-stimulated cells adherent
to plated Fg (Fig. 2A). Phosphorylation of Pyk2 was
observed within 5 min and was maximal at 20 min.
Both tyrosine phosphorylation of Pyk2 and adhesion of
dHL60 cells to Fg-coated plates were dependent on adhe-
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common β chain of β2-integrin, CD18, substantially
attenuated Pyk2 phosphorylation elicited by fMLP as
demonstrated by Western blot analysis. Mouse IgG1 iso-
type control had no effect on Pyk2 phosphorylation
caused by adhesion (Fig. 2B). Similarly, adhesion of
dHL60 cells to plated Fg caused by fMLP was significantly
reduced by preincubation with anti-CD18 mAb. Mouse
IgG1 caused no blockade of fMLP-induced adhesion (Fig.
2C). Adhesion of dHL60 cells to Fg-coated plates
increased from 4.9 ± 0.9% (negative control) to 19.6 ±
1.4% (fMLP-treated; p < 0.01). Preincubation with anti-
CD18 mAb blocked fMLP stimulated adhesion to 1.4 ±
1.2% (p < 0.01 vs. fMLP-treated positive control).
Effect of TAT-Pyk2-CT on adhesion of dHL60 cells to plated 
fibrinogen
Pyk2 had no effect in causing adhesion of dHL-60 cell
elicited by fMLP. Adhesion of dHL60 cells to plated Fg
increased from 7.7 ± 1.0% to 19.6 ± 1.4% after treatment
with 10-6 M fMLP for 30 min. Pretreatment with TAT-
Pyk2-CT, a selective cell permeable dominant negative
protein inhibitor of Pyk2 [10,15], did not block adhesion
of dHL60 cells to plated Fg induced by fMLP (Fig. 2D).
These results suggest that Pyk2 has no regulatory role in
the induction of adhesion caused by the β2-integrin.
Effect of Pyk2 inhibition on fMLP-induced transwell 
migration of dHL60 cells
fMLP induced concentration-dependent transwell migra-
tion of dHL60 cells (Fig. 3A). Similar to human neutro-
phils [21], the number of dHL60 cells that migrated
through the transwell filter decreased at higher concen-
trations than 10-8 M due to saturating diffusion of fMLP
Figure 1 Pyk2 expression in HL60 cells differentiated by DMSO. A) 
HL60 cells were induced to differentiate toward neutrophil-like cells. 
HL60 cells were lysed before and 3 to 5 days after differentiation, and 
Pyk2 expression in these cells was analyzed by Western blot using anti-
Pyk2 antibody. B) Pyk2 expression in dHL60 cells as compared with hu-
man blood neutrophils. Pyk2 expression was measured as above. Rep-
resentative blot is shown (n = 3).
Figure 2 Tyrosine phosphorylation of Pyk2 induced by fMLP in 
dHL-60 cells adhering to plated fibrinogen. A) dHL-60 cells were ei-
ther in suspension or added to plated fibrinogen, and then stimulated 
with 1 μM fMLP for indicated times at 37°C. Pyk2 activation was mea-
sured by its autophosphorylation detected by Y402 phosphorylation-
specific antibody (upper panel). Total Pyk2 expression was measured 
by Western blot using anti-Pyk2 antibody (lower panel). B) Effect of 
anti-β2 integrin antibody on phosphorylation of Pyk2 induced by fMLP 
in adherent dHL60 cells. dHL60 cells were preincubated with 10 μg/ml 
antibody against CD18 for 30 min, and then added to Fg-coated plates 
with 1 μM fMLP for 10 min. Pyk2 tyrosine phosphorylation was then 
measured as above. C) Effect of anti-β2 integrin antibody on phospho-
rylation of Pyk2 induced by fMLP in adherent dHL60 cells. dHL60 cells 
were preincubated with 10 μg/ml anti-CD18 antibody for 30 min, and 
then added to Fg-coated plates with 1 μM fMLP for 30 min. Adhesion 
of dHL60 cells to plated Fg was then measured as residual myeloper-
oxidase assay. Results are presented as the mean ± SEM from 4 sepa-
rate experiments. **p < 0.01 vs. fMLP alone, Fisher's LSD test. D) Effect 
of TAT-Pyk2-CT on adhesion of dHL-60 cells to plated fibrinogen. dHL-
60 cells were preincubated with indicated concentrations of TAT-Pyk2-
CT and then adhered to plated fibrinogen for 30 min in the presence 
of 1 μM fMLP. Adhesion of dHL-60 cells was measured by residual my-
eloperoxidase activity assay. Results are presented as the mean ± SEM 
from 4 separate experiments.
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selected as the optimal concentration for subsequent
migration assays.
TAT-Pyk2-CT blocked migration of dHL60 cells in
concentration-dependent manner (Fig. 3B). Migration of
dHL60 increased from 9.2 ±2.6% to 27.4 ± 3.6% in
response to fMLP. TAT-Pyk2-CT, which caused no inhi-
bition of cell adhesion (see above), significantly blocked
transwell migration of dHL60 cells. TAT-Pyk2-CT
decreased cell migration to 16.0 ± 5.1% at 0.2 μM (p <
0.05) and to 10.4 ± 0.2% at 2 μM (p < 0.01). A control TAT
protein, TAT-Green fluorescent protein (TAT-GFP), had
no inhibitory effect on migration of dHL60 cells at 2 μM.
To confirm the specificity of inhibition of Pyk2 activa-
tion caused by TAT-Pyk2-CT, dHL60 cells were preincu-
bated with 2 μM TAT-Pyk2-CT or TAT-GFP for 30 min
and then stimulated with fMLP in Fg-coated plates. TAT-
Pyk2-CT inhibited Pyk2 autophosphorylation elicited by
fMLP (Fig. 3C). By contrast, TAT-GFP had no effect on
Pyk2 phosphorylation caused by fMLP in adherent
dHL60 cells.
Effect of TAT-Pyk2-CT on fMLP-stimulated spreading of 
dHL60 cell
Pyk2 was essential for spreading of dHL-60 cells caused
by 10-6 M fMLP on Fg-coated plates (Figs 4A and 4B). In
the unstimulated control state (Fig. 4A), cells were
rounded and non-specifically adherent, which accounts
for their brighter appearance. fMLP-stimulated dHL60
cells occupied a larger surface area in contact with the
substratum than non-stimulated cells. Phase contrast
microscopy revealed dark and irregularly shaped cells
after treatment with fMLP compared to controls (Fig.
4B). Spreading of adherent dHL60 cells on Fg coated
plates was blocked by dominant negative TAT-Pyk2-CT
(Fig. 4C). Phase-contrast microscopy demonstrated only
minimal irregularity in dHL-60 cell shape after TAT-
Pyk2-CT. Blockade caused by TAT-Pyk2-CT was specific.
Pretreatment with TAT-GFP did not block cell spreading
(Fig. 4D), and morphology was similar to untreated cells
(Fig. 4A).
FMLP also caused formation of filopodia and lamelli-
podia (Fig. 4B). Formation of these structure also was
blocked by TAT-Pyk2-CT (Fig. 4C), but not by TAT-GFP
(Fig. 4D).
Figure 4 Effect of Pyk2 inhibition on spreading of dHL60 cells on 
plated fibrinogen. dHL-60 cells were preincubated with indicated 
concentrations of 2 μM TAT-Pyk2-CT (C) or TAT-GFP (D) for 15 min at 
37°C, and adhered to plated fibrinogen for 30 min in the absence (A) or 
presence (B-D) of 1 μM fMLP. Cell morphology was analyzed by light 
microscopy. Representative images were shown from three experi-
ments. Filled arrow points to lamellipodia, and empty arrow points to 
filopodia.
Figure 3 A) Concentration-dependent effect of fMLP on migra-
tion of dHL60 cells through a transmembrane filter. An increased 
concentration of fMLP was added to the bottom wells while the dHL60 
cells were added on to the top plates. dHL60 cell migration was quan-
titated by MPO activity of the bottom wells. Results are presented as 
the mean ± SEM from 4 separate experiments. ** p < 0.01 vs. buffer 
control by Fisher's LSD test. B) Effect of TAT-Pyk2-CT on chemotaxis of 
dHL-60 cells to 10-8 M fMLP. dHL-60 cells were preincubated with TAT-
Pyk2-CT or TAT-GFP and were added on the top plate of the migration 
system. dHL-60 cell migration in response to 10-8 M fMLP was mea-
sured after 90 min. Results are presented as the mean ± SEM from 4 
separate experiments. *P < 0.05 and **p < 0.01 vs. fMLP alone by Fish-
er's LSD test. C) Effect of TAT-Pyk2-CT on autophosphorylation of Pyk2 
induced by fMLP in adherent dHL60 cells. dHL60 cells were preincu-
bated with 2 μM TAT-Pyk2-CT or 2 μM TAT-GFP for 30 min, and then 
added to Fg-coated plates with 1 μM fMLP for 10 min. Pyk2 phospho-
rylation was detected by Y402 phosphorylation-specific antibody (up-
per panel). Total Pyk2 expression was detected by anti-Pyk2 antibody 
(lower panel). Representative blot is shown (n = 3).
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plated fibrinogen
Pyk2 is tyrosine phosphorylated during cell adhesion
[15]. In buffer-treated adherent cells, phospho-Pyk2 was
localized uniformly and circumferentially around the cell
membrane (Fig. 5A). In cells in which 10-6 M fMLP
caused cell spreading, phospho-Pyk2 was distributed
almost entirely in the periphery, corresponding to the
shape of the cell (Fig. 5B). Phospho-Pyk2 was visualized
in highest concentration at the leading edge of spreading
HL-60 cells. In fMLP stimulated non-spreading cells, the
localization of phospho Pyk2 was similar to the non-stim-
ulated cells (Fig. 5C). Phospho-Pyk2 also co-localized
with F-actin at the leading edge of the lamellipodia (Fig.
5C).
Effect of silencing Pyk2 on dHL60 cell migration
Pyk2 siRNA reduced the expression of Pyk2 protein by
~85% as compared to vehicle control (Nucleofector Solu-
tion V only), analyzed by Western blot and densitometry.
By contrast, the scramble siRNA control had no effect on
Pyk2 protein expression (Fig. 6A).
Silencing of Pyk2 expression significantly reduced the
migration of dHL60 cells compared to cells treated with
Nucleofector Solution V vehicle control or scramble
siRNA control. Pyk2 siRNA reduced migration of dHL60
cells to fMLP from 25.9 ± 3.8% of vehicle control to 16.6 ±
2.2% (p < 0.05, vs. vehicle control or scramble siRNA).
The scramble non-targeting siRNA had no effect on
dHL60 cell migration to fMLP (NS vs. vehicle control).
Pyk2 siRNA had no effect on dHL60 cells differentiation
as measured by nuclear morphology and CD11b surface
expression (data not shown).
Discussion
The objective of this investigation was to determine the
role of Pyk2 in dHL60 cell migration. We found that 1)
Pyk2, especially the hematopoietic form of Pyk2, is
induced after neutrophilic differentiation and is tyrosine
phosphorylated upon adhesion to plated fibrinogen, 2)
Pyk2 does not regulate β2-integrin adhesion of dHL60
cells to fibrinogen, as inhibition of Pyk2 by TAT-Pyk2-CT
does not block cell adhesion, 3) Pyk2 is essential for
dHL60 migration, as both inhibition of Pyk2 activity or
silencing of Pyk2 expression reduced the migration of
dHL60 cells, and 4) Pyk2 is concentrated to the cell mem-
brane extensions in migrating dHL60 cells.
Pyk2 is a non-receptor protein tyrosine kinase that is
closely related to the p125 focal adhesion kinase (Fak).
Here we report that both forms of Pyk2 are induced in
DMSO-differentiated cells, and the alternatively spliced,
hematopoietic form of Pyk2 (Pyk2H) is the predominant
isoform expressed in dHL60 cells. Pyk2-H is mainly
expressed in hematopoietic cells including T-cells, B-
Figure 5 Localization of Pyk2 in unstimulated and fMLP-stimulat-
ed adherent dHL-60 cells. dHL-60 cells (2 × 105) were added to fibrin-
ogen-coated 8-well chamber slides with or without 1 μM fMLP for 30 
min. Pyk2 localization in unstimulated (A) or fMLP-stimulated cells (B-
C) was detected by anti-phospho Pyk2 antibody. Phospho-Pyk2 was 
localized adjacent to cell membrane as a round circle in non-stimulat-
ed control cells, while it concentrates on pseudopods and uropods of 
polarizing cells (B) in a punctate staining after fMLP stimulation. The 
lower panel of figure A and B were transmission images. C) Colocaliza-
tion of Pyk2 and F-actin in dHL-60 at lamellipodia. dHL-60 cells (2 × 105) 
were added to fibrinogen-coated 8-well chamber slides with 1 μM 
fMLP for 30 min. Pyk2 localization in dHL-60 cells was detected by anti-
phospho Pyk2 antibody (Green, upper left). F-actin was detected by Al-
exa Fluor 647 phalloidin staining (Red, upper right). The transmission 
image was shown in lower left, and the colocalization of Pyk2 and F-
actin was shown in lower right in yellow. Representative images were 
shown from four experiments. Arrow points the colocalization in 
lamellipodia.
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CD34+ bone marrow progenitor cells and myeloid leuke-
mic cells [23,24]. The two Pyk2 isoforms appear function-
ally redundant for inhibiting integrin-mediated
myelopoiesis when singly overexpressed in primary
CD34+ cells [24]. Stimulation of dHL60 cells with fMLP in
fibrinogen-coated plates induced the tyrosine phospho-
rylation of both forms of Pyk2 (Fig. 2A, 2B), while mini-
mal phosphorylation is detected in suspension cells.
Adhesion of dHL60 cells to plated Fg is mediated by β2-
integrin; as preincubation with anti-CD18 antibody
blocked dHL60 cell adhesion to plated fibrinogen. Previ-
ous studies have suggested that Pyk2 is involved in the
functional activation of dHL60 cells in two signaling
pathways: an fMLP receptor-mediated "inside-out" sig-
naling pathway that can cause β2 integrin activation and a
subsequent β2 integrin-mediated "outside-in" signaling
pathway [19], although the functional activation of integ-
rin was not determined in that study. Our results indicate
that Pyk2 is not involved in fMLP induced inside-out sig-
naling for increased adhesiveness of β2 integrin, as Pyk2
inhibition by TAT-Pyk2-CT had no inhibitory effect on
adhesion of dHL60 cells to plated fibrinogen (Fig. 2D).
We also found that preincubation of dHL60 cells with
anti-CD18 blocks both cell adhesion and Pyk2 phospho-
rylation (Fig. 2B, 2C). These results indicate that tyrosine
phosphorylation of Pyk2 is activated after β2-integrin
binding to plated Fg and is required for β2 integrin medi-
ated outside-in signaling for subsequent cell spreading
and migration (see below).
Integrin-mediated adhesive interactions with substrate
proteins play a critical mechanical role in the morpho-
logic change of cells and migration by linking the extra-
cellular matrix proteins to the intracellular cytoskeleton.
In this study, Pyk2 inhibition by TAT-Pyk2-CT dramati-
cally reduced the extension of cell membranes on Fg-
coated plates and the formation of large lamellipodia (Fig.
4C), suggesting that Pyk2 activation plays a key role in the
morphological change following cell adhesion. The
extension of lamellipodia, filopodia and other membrane
processes depends on reorganization of the actin
cytoskeleton as well as the formation of new actin poly-
mers that support membrane protrusions [25]. We found
that Pyk2 and F-actin are colocalized and concentrated in
lamellipodia of migrating dHL60 cells (Fig. 5C). Further-
more, Pyk2 inhibition by TAT-Pyk2-CT prevented the
formation of large lamellipodia (Fig. 4C). These results
suggest that integrin-mediated Pyk2 activation may play a
role in cytoskeletal reorganization during dHL60 cell
spreading and migration.
Cell spreading and the extension of membrane pro-
cesses play an essential role in cell migration. During
chemoattractant-induced neutrophil migration, cells
assume a polarized morphology and then spread and
extend membrane processes in the direction of move-
ment as they move along extracellular matrix compo-
nents in response to a gradient of chemoattractant.
Integrin-mediated adhesion at the leading edge of the
migrating cell provides the traction necessary for forward
movement [26]. Such directional movement is essential
for neutrophils to enter into sites of infection to fight bac-
teria. Our findings suggest that Pyk2 may regulate integ-
rin-mediated extension of membrane processes and
provide a possible mechanism by which Pyk2 promotes
dHL60 cell migration (Fig. 3).
Figure 6 Effect of silencing Pyk2 expression on chemotaxis of 
dHL-60 cells to fMLP. A) Representative Western blot of Pyk2 expres-
sion in dHL60 cells (top panel). dHL-60 cells were resuspended in nu-
cleofector solution V (V), and then transfected with 2 μM Pyk2 siRNA 
(sipyk2) or non-targeting scramble control siRNA (scram). Pyk2 expres-
sion in dHL60 cells was measured 3 days after transfection by Western 
blotting analysis using anti-Pyk2 antibody, and equal protein loading 
was verified by anti-β actin antibody. The bottom panel was the den-
sitometric analysis of Pyk2 bands from three blots. **P < 0.01 vs. nucle-
ofector solution V vehicle control or scramble control using paired t 
test. B). Effect of silencing Pyk2 expression on migration of dHL60 cells. 
Migration assays were performed 72 h after transfection on Transwell 
plates as above. Migration in response to 10-8 M fMLP was measured af-
ter 90 min. Results are presented as the mean ± SEM from 3 separate 
experiments. *P < 0.05 vs. nucleofector solution V vehicle control or 
scramble control using paired t test.
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cells (~85%) only blocked the chemotaxis of dHL60 cells
by ~46%. One explanation for the incomplete inhibition
of migration is that the residual Pyk2 expression after
knockdown is sufficient to enable some chemotaxis.
Another possibility is that multiple parallel pathways
exist in cells that enable cell chemotaxis. It has been
found that four independent signaling pathways lead to
the chemotaxis of Dictyostelium discoideum cells; these
are phosphoinositide-3 kinase, phospholipase A2, soluble
guanylyl cyclase, and cGMP [27]. Similarly in human
neutrophils, both phosphoinositide-3 kinase and p38
MAP kinase regulate chemotaxis in a fMLP gradient
[28,29]. A recent study in dHL60 cells found that phos-
phoinositide-3 kinase and Src pathways work in parallel
to modulate chemotaxis to IL-8 [20]. Other studies have
found that Pyk2 is the upstream kinase for Src activation
[30,31]. Therefore, it is reasonable to speculate that Pyk2
knockdown in dHL60 cells impairs only the Src-mediated
dHL60 chemotaxis pathway, while other parallel path-
ways may enable some residual chemotaxis capability as
observed in this study.
It is important to recognize some other limitations of
our findings. We used the differentiated HL-60 cells to
model human neutrophils as these dHL60 cells can be
modified genetically. Although the differentiated HL-60
cells have many features that mimic mature human neu-
trophils [13,32,33], such as CD11b/CD18 expression,
responsiveness to fMLP and other chemoattractants,
have a segmented nucleus, these cells are nevertheless
far-different from mature neutrophils, as they lack the
ability to synthesize granular proteins as well as to form
granules [34]. Cell adhesion and migration occurred only
in 20-30% of cells. This fraction is however similar to that
for mature PMN [35]. This likely represents a limitation
of the adhesion and migration apparatuses rather than
heterogeneity in dHL60 and PMN cells. Additionally, the
isoform of Pyk2 expressed in dHL60 cells is different
from that of mature neutrophils, with dHL60 predomi-
nantly expressing the hematopoietic form while mature
neutrophils expressed the full-length form. However, no
functional difference between these two isoforms has
been elucidated previously. The use of dHL60 cells was
essential because a relative long-lived cell model was
required for these siRNA silencing studies.
Conclusions
In summary, we find that β2-integrin adhesion of dHL60
cells induces activation of Pyk2. Specific inhibition of
Pyk2 by TAT-Pyk2-CT causes a substantial attenuation of
dHL60 cell spreading and migration, but has no effect on
cell adhesion, suggesting a critical role for Pyk2 in mor-
phological change and migration of neutrophilic dHL60
cells.
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